Email this article 
Pimecrolimus 1 % cream in treatment of steroid rosacea in AD patients
- Authors: Elisyutina OG1, Fedenko ES1
-
Affiliations:
- Institute of Immunology
- Issue: Vol 7, No 4 (2010)
- Pages: 54-57
- Section: Articles
- URL: https://rusalljournal.ru/raj/article/view/890
- DOI: https://doi.org/10.36691/RJA890
- ID: 890
Cite item
Open Access
Access granted
Subscription or Fee Access
Abstract
The own data concerning cream pimecrolimus 1% application in atopic dermatitis patients complicated with steroid rosacea are presented.
Keywords
About the authors
O G Elisyutina
Institute of Immunology
Email: el-olga@yandex.ru
Institute of Immunology
E S Fedenko
Institute of ImmunologyInstitute of Immunology
References
- Akdis С. A Review article Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology. American Academy of Allergy, Asthma and Immunology. PRACTALL Consensus report. Allergy. 2006, v. 61, p. 969-987.
- Barnes PJ. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. J. Allergy Clin. Immunology. 2000, v. 106, p. 5-16.
- Емельянов А.В., Монахов К.Н. Молекулярные механизмы действия топических глюкокортикоидов: значение внегеномного эффекта. Укр. журн. дерматол., венерол. и косметол. 2003, № 3, с. 38-40.
- Leyden J.J., ThewM., KligmanA.M. Steroid rosacea. Arch. Dermatol. 1974, v. 110, p. 619-622.
- Harlan S.L. Steroid acne and rebound phenomenon. J. Drugs Dermatol. 2008, v. 7 (6), p. 547-550.
- Акнеирозацеа. Подред. Н.Н. Потекаева. М., «Издательство Бином». 2007, 216 с.
- Lee D.H., Li К., Suh D.H. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial. Br. J. Dermatol. 2008, v. 158 (5), p. 1069-1076.
- Weissenbacher S., Merkl J., Hildebrandt B. et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br. J. Dermatol. 2007, v. 156 (4), p. 728-732.
- Scheinfeld N., Berk T. A review of the diagnosis and treatment of rosacea. Postgrad Med. 2010, v. 22 (1), p. 139-143.
- Korting H.C, Schollmann C. Current topical and systemic approaches to treatment of rosacea. J. Eur. Acad. Dermatol. Venereol. 2009, v. 23 (8), p. 876-882.
- Hultsch T. et al. Ascomycin macro lactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. Arch. Dermatol. Res. 1998, v. 290, p. 501-507.
- Kapp A. et al. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J. Allergy Clin. Immunol. 2002, v. 110, p. 277-284.
- Meurer M. et al. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: A six-month study. Dermatology. 2002, v. 205, p. 271-277.
- MunzenbergerPJ., Montejo J.M. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Pharmacotherapy. 2007, v. 27 (7), p. 1020-1028.
Supplementary files
